Stock earnings page

Outlook Therapeutics, Inc. (OTLK)

Track the next or latest earnings date for Outlook Therapeutics, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

[10-Q] Outlook Therapeutics, Inc. Quarterly Earnings Report | OTLK Quarterly Report (10-Q)
www.stocktitan.net · 1 week ago

Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.

Outlook Therapeutics (OTLK) Reports Q2 Revenue Below Expectations
www.gurufocus.com · 1 week ago

GuruAI Model Portfolios All-In-One ... Calendar Earnings Calendar & Reports Analyst Ratings Embed Widgets Stock Market Holidays Transcripts Search ... Chat Support Create a ticket User Engagement Meeting 469-248-6885 Status Take Survey Give us your feedback ... On May 15, 2026, Outlook Therapeutics …

BTIG downgrades Outlook Therapeutics stock rating to neutral By Investing.com
www.investing.com · 5 days ago

Investing.com - BTIG downgraded Outlook Therapeutics Inc. (NASDAQ:OTLK) to Neutral from Buy, citing the need for clarity on the path to U.S. approval and stronger commercial momentum in Europe before becoming more constructive on the stock.

Outlook Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary — TradingView News
www.tradingview.com · 1 week ago

FORECAST CHANGESRECOMMENDATIONSThis summary was machine generated from LSEG data May 15 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact ...

Outlook Therapeutics stock (US69012T1051): FDA feedback and capital raise keep focus on wet AMD path
www.ad-hoc-news.de · 6 days ago

Outlook Therapeutics is back in focus after recent FDA feedback on its wet AMD therapy and a fresh capital raise to extend its cash runway. What this could mean for the ONS-5010 program and the Nasdaq-listed biotech’s risk profile.

Latest earnings date

Feb 13, 2026

Time not specified

Fiscal quarter: Dec/2025

EPS estimate: -$0.17

Revenue estimate: N/A

Market cap: $32.42M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Feb 13, 2026	Dec/2025	Time not specified	-$0.17	N/A